Page last updated: 2024-08-24

triazoles and Carcinosarcoma

triazoles has been researched along with Carcinosarcoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbea, L; Cano, D; Hernandez-Lizoain, JL; Idoate, MA; Jurado, M; Martin-Algarra, S; Martin-Romano, P; Paramo, JA1
Bellini, E; Berchuck, A; Bernasocchi, T; Bertoni, F; Bielski, CM; Broaddus, RR; Carney, ME; Carr, SA; Cascione, L; Catapano, CV; Civenni, G; El Tekle, G; Enchev, RI; Garraway, LA; Janouskova, H; Kryukov, GV; Losa, M; Moch, H; Mutch, DG; Napoli, S; Peter, M; Rinaldi, A; Schraml, P; Svinkina, T; Theurillat, JP; Udeshi, ND; Ulbricht, A; Wild, PJ; Winterhoff, BJN1
Baron, M; d'Anjou, J; Dessogne, P1

Other Studies

3 other study(ies) available for triazoles and Carcinosarcoma

ArticleYear
Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
    Journal of medical case reports, 2017, Apr-19, Volume: 11, Issue:1

    Topics: Aromatase Inhibitors; Blood Coagulation Disorders; Bone Neoplasms; Carcinosarcoma; Female; Humans; Letrozole; Lymphatic Metastasis; Middle Aged; Nitriles; Remission Induction; Shock; Triazoles; Uterine Hemorrhage; Uterine Neoplasms

2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
    Nature medicine, 2017, Volume: 23, Issue:9

    Topics: Acetanilides; Adenocarcinoma, Clear Cell; Animals; Apoptosis; Azepines; Carcinoma, Endometrioid; Carcinosarcoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Cullin Proteins; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epigenesis, Genetic; Female; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Male; Mass Spectrometry; Mice, Nude; Molecular Targeted Therapy; Mutation; Neoplasm Transplantation; Neoplasms, Cystic, Mucinous, and Serous; Nuclear Proteins; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Transcription Factors; Triazoles; Ubiquitination

2017
[The uterine sarcoma, a new risk identified for tamoxifen].
    Presse medicale (Paris, France : 1983), 2004, Mar-13, Volume: 33, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinosarcoma; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Humans; Metrorrhagia; Middle Aged; Neoplasms, Second Primary; Nitriles; Risk; Tamoxifen; Triazoles; Uterine Neoplasms

2004